Skip to content

Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)

Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03657875
Enrollment
53940
Registered
2018-09-05
Start date
2017-09-15
Completion date
2017-09-15
Last updated
2018-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkalemia Elevated Plasma K+ Cardiovascular Disease (CVD)

Brief summary

This is a cross-sectional retrospective study of laboratory records of patients who take electrolytes blood tests containing the data of the serum potassium level. This study is an observational one, and there is no intervention into routine clinical practice either in terms of therapy, or special examinations.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Males and females tested in the Russian centres of INVITRO laboratory from 01.01.2015 till 31.12.2016; * 18 years and older; * Available electrolytes blood test containing of the serum potassium level of the unique patient fits for interpretation.

Exclusion criteria

* Blood test cannot be interpreted due to various reasons. * Blood samples with sing of hemolysis

Design outcomes

Primary

MeasureTime frameDescription
the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/LOne dayTo determine the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/L based on INVITRO laboratory database during 2015-2016 years.

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026